Quotient Limited (QTNT) to Release Quarterly Earnings on Monday
Quotient Limited (NASDAQ:QTNT) will be announcing its earnings results after the market closes on Monday, October 30th. Analysts expect the company to announce earnings of ($0.59) per share for the quarter.
Quotient Limited (NASDAQ:QTNT) last announced its quarterly earnings results on Monday, August 7th. The company reported ($0.55) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.55). Quotient Limited had a negative return on equity of 13,050.41% and a negative net margin of 381.66%. The firm had revenue of $6.83 million for the quarter, compared to analysts’ expectations of $5.70 million. On average, analysts expect Quotient Limited to post $-2.09 EPS for the current fiscal year and $-1.15 EPS for the next fiscal year.
Shares of Quotient Limited (QTNT) traded down 1.48% during mid-day trading on Monday, reaching $4.65. The company’s stock had a trading volume of 47,955 shares. The firm’s market cap is $66.85 million. The firm has a 50 day moving average price of $4.59 and a 200 day moving average price of $5.90. Quotient Limited has a 52-week low of $3.22 and a 52-week high of $7.74.
Several equities analysts have weighed in on the company. ValuEngine raised Quotient Limited from a “strong sell” rating to a “sell” rating in a report on Friday, June 30th. Zacks Investment Research raised Quotient Limited from a “sell” rating to a “hold” rating in a report on Wednesday, September 20th. Finally, BTIG Research reaffirmed a “buy” rating and issued a $12.00 price objective on shares of Quotient Limited in a report on Thursday, August 31st.
In related news, insider D J. Paul E. Cowan sold 45,540 shares of the business’s stock in a transaction on Monday, August 21st. The stock was sold at an average price of $3.52, for a total transaction of $160,300.80. Following the sale, the insider now owns 26,666 shares in the company, valued at approximately $93,864.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider D J. Paul E. Cowan sold 30,197 shares of the business’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $4.92, for a total value of $148,569.24. Following the sale, the insider now owns 26,666 shares in the company, valued at approximately $131,196.72. The disclosure for this sale can be found here. Insiders have sold a total of 375,197 shares of company stock worth $1,639,728 in the last 90 days. 29.00% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently modified their holdings of the stock. The Manufacturers Life Insurance Company bought a new stake in Quotient Limited during the 2nd quarter worth $177,000. California State Teachers Retirement System bought a new stake in Quotient Limited during the 2nd quarter worth $349,000. Vanguard Group Inc. bought a new stake in Quotient Limited during the 2nd quarter worth $523,000. Finally, State Street Corp bought a new stake in Quotient Limited during the 2nd quarter worth $1,728,000. Institutional investors and hedge funds own 57.71% of the company’s stock.
Quotient Limited Company Profile
Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market.
Receive News & Ratings for Quotient Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient Limited and related companies with MarketBeat.com's FREE daily email newsletter.